AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Egetis Therapeutics

Major Shareholding Notification Oct 12, 2023

3152_iss_2023-10-12_1cbece6f-ce1c-4b3a-a363-e5ad85624221.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Issuer Egetis Therapeutics AB (publ)

Holder

FHMLSP, L.L.C.

Instrument

Instrument Share SE0003815604
Before the transaction
Shares 0
Voting rights 0
Transaction
Reason for major shareholding notification New share issue
Date 10/10/2023
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 17,017,220
Directly held voting rights 0
Indirectly held voting rights 17,017,220
Percentage
Directly held shares 5.82 %
Directly held voting rights 0 %
Indirectly held voting rights 5.82 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 5.82 % 17,017,220
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 5.82 % 17,017,220

Chain of controlling companies

Voting rights % Voting rights Company
0 0 FHMLSP, L.P.
17,017,220 5.82 Frazier Life Sciences Public Fund, L.P.
Group total holdings
Voting rights 17,017,220
Percentage of voting rights 5.82

Notes (other relevant informations according to law)

This notification is made pursuant to Frazier Life Sciences Public Fund, L.P.'s subscription of shares in the directed share issue in Egetis Therapeutics AB (publ). FHMLSP, L.L.C. is the sole general partner of and controls FHMLSP, L.P. and FHMLSP, L.P. is the sole general partner of and controls Frazier Life Sciences Public Fund, L.P. which has subscribed for 17,017,220 shares in the directed share issue in Egetis Therapeutics AB (publ). As a result of Frazier Life Sciences Public Fund, L.P.'s holding of shares in Egetis Therapeutics AB (publ), FHMLSP, L.L.C. indirectly holds 17,017,220 shares and votes in Egetis, representing 5,82% of the outstanding share capital and votes in Egetis Therapeutics AB (publ). FHMLSP, L.L.C. submits this notification on behalf of FHMLSP, L.P., Frazier Life Sciences Public Fund, L.P. and on its own behalf.

Published

12/10/2023 20:49

Contact

Name Gordon Empey

Phone +12069545429 Email [email protected]

Talk to a Data Expert

Have a question? We'll get back to you promptly.